Unknown

Dataset Information

The pharmacogenomic landscape of an Indigenous Australian population.


ABSTRACT: Background: Population genomic studies of individuals of Indigenous ancestry have been extremely limited comprising <0.5% of participants in international genetic databases and genome-wide association studies, contributing to a "genomic gap" that limits their access to personalised medicine. While Indigenous Australians face a high burden of chronic disease and associated medication exposure, corresponding genomic and drug safety datasets are sorely lacking. Methods: To address this, we conducted a pharmacogenomic study of almost 500 individuals from a founder Indigenous Tiwi population. Whole genome sequencing was performed using short-read Illumina Novaseq6000 technology. We characterised the pharmacogenomics (PGx) landscape of this population by analysing sequencing result

SUBMITTER: Samarasinghe SR 

PROVIDER: S-EPMC10241071 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature